SAN ANTONIO — Recent findings from the INSEMA trial provided more evidence that omitting axillary sentinel lymph node biopsy (SLNB) does not compromise survival in women with low-risk, early-stage ...
Women with node-negative breast cancers 2 cm or smaller and negative preoperative axillary ultrasound results may be safely spared sentinel lymph node biopsy (SLN) biopsy, new research suggests. SLN ...
However, omission does result in reductions in neutropenia, thrombocytopenia, and use of granulocyte colony-stimulating factor. HealthDay News — Omission of 5-fluorouracil (5-FU) from the first-line ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results